SeekingAlpha · Sep 23, 2026
BTX: AI Technology Trading At A Deep Discount
BTX is rated a Buy and offers diversified public and private equity exposure centered on the AI investment theme. Read more on the fund here.

NASDAQ · BTX
Healthcare · Biotechnology
$9.22
Up+$0.06 (+0.66%)
Updated Oct 3, 2026, 11:38 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BTX
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
BTX closed at $9.22 after 20 trading sessions, up 3.13% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $9.30 | $9.3297 | $9.22 | $9.22 | 487.34K |
| Oct 1, 2026 | $9.02 | $9.23 | $8.98 | $9.16 | 652.65K |
| Sep 30, 2026 | $9.03 | $9.0498 | $8.955 | $8.98 | 611.26K |
| Sep 29, 2026 | $8.97 | $8.99 | $8.8799 | $8.95 | 519.66K |
| Sep 28, 2026 | $9.01 | $9.049 | $8.82 | $8.86 | 365.29K |
| Sep 25, 2026 | $9.04 | $9.065 | $8.97 | $9.04 | 306.06K |
| Sep 24, 2026 | $8.84 | $8.995 | $8.84 | $8.98 | 360.38K |
| Sep 23, 2026 | $9.05 | $9.07 | $8.98 | $8.98 | 421.38K |
| Sep 22, 2026 | $8.94 | $9.08 | $8.92 | $9.05 | 339.83K |
| Sep 21, 2026 | $8.85 | $9.09 | $8.84 | $8.96 | 264.07K |
| Sep 18, 2026 | $8.82 | $8.82 | $8.74 | $8.77 | 392.65K |
| Sep 17, 2026 | $8.80 | $8.80 | $8.58 | $8.73 | 312.74K |
| Sep 16, 2026 | $8.75 | $8.75 | $8.565 | $8.67 | 418.9K |
| Sep 15, 2026 | $8.60 | $8.771 | $8.46 | $8.46 | 705K |
| Sep 14, 2026 | $8.70 | $8.71 | $8.59 | $8.67 | 340.24K |
| Sep 11, 2026 | $9.01 | $9.01 | $8.825 | $8.87 | 301.44K |
| Sep 10, 2026 | $8.82 | $8.90 | $8.80 | $8.81 | 346.33K |
| Sep 9, 2026 | $9.01 | $9.13 | $8.96 | $8.96 | 356.94K |
| Sep 8, 2026 | $9.00 | $9.06 | $8.94 | $9.01 | 299.09K |
| Sep 4, 2026 | $8.87 | $8.95 | $8.83 | $8.94 | 282.34K |
The latest Smart Investors Daily articles mentioning BTX.
Company
Market Activity
Research & News
BTX research
Company profile and research snapshot.
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2022 | Maxim Group | Hold | — |
| Dec 29, 2021 | Cantor Fitzgerald | Overweight | — |
| Oct 6, 2021 | Maxim Group | Buy | — |
| Mar 18, 2019 | Raymond James | Outperform | — |
| Feb 21, 2019 | H.C. Wainwright | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 23, 2026
BTX is rated a Buy and offers diversified public and private equity exposure centered on the AI investment theme. Read more on the fund here.
SeekingAlpha · Jul 8, 2026
BlackRock Technology and Private Equity Term Trust aims for 80% tech exposure, blending public and private holdings. Read the full analysis here.
businesswire.com · Nov 28, 2025
NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BTX.